251. A panel of platelet-associated circulating long non-coding RNAs as potential biomarkers for colorectal cancer
- Author
-
Yulin Xie, Bingqi Ye, Huisi Ding, Chao Qi, Qikun Zhang, Yu Weng, Xiangwei Gao, Fengying Li, Mengsha Chen, and Jun Zhang
- Subjects
Platelet associated ,Colorectal cancer ,Cancer ,RNA ,Biology ,medicine.disease ,Gene Expression Regulation, Neoplastic ,ROC Curve ,Downregulation and upregulation ,Biomarkers, Tumor ,Genetics ,Cancer research ,medicine ,Humans ,Biomarker (medicine) ,RNA, Long Noncoding ,Platelet ,Colorectal Neoplasms ,Cell-Free Nucleic Acids ,Biomarkers ,Cancer staging - Abstract
Evidence has suggested the potential of tumor-educated platelets as a biomarker trove for cancer diagnostics, but the difficulty in isolation limits its application. Since most of the circulating RNAs are derived from platelets, the change of RNA profile in platelets may lead to altered RNA expression in serum. Here, we identified a panel of platelet-associated long non-coding RNAs (lncRNAs) and evaluated its diagnostic capacity in serum of colorectal cancer (CRC) patients. Four lncRNAs, LNCAROD, SNHG20, LINC00534, and TSPOAP-AS1, were upregulated in both platelets and serum of CRC patients. A binary logistic model derived from them has validated area under roc curve of 0.78 indicating great performance. Furthermore, the expression levels of LNCAROD and TSPOAP-AS1 were correlated with cancer staging and tumor location. Together, our results add novel lncRNA biomarkers to the list of blood tests for CRC diagnostics and provide molecular evidence for the cross-talk between CRC platelets and serum.
- Published
- 2022